SPRINKLR INC-A (CXM)

US85208T1079 - Common Stock

9.87  +0.27 (+2.81%)

After market: 9.38 -0.49 (-4.96%)

Fundamental Rating

5

CXM gets a fundamental rating of 5 out of 10. The analysis compared the fundamentals against 284 industry peers in the Software industry. CXM has an average financial health and profitability rating. CXM has a correct valuation and a medium growth rate.



5

1. Profitability

1.1 Basic Checks

CXM had positive earnings in the past year.
In the past year CXM had a positive cash flow from operations.
CXM had negative earnings in 4 of the past 5 years.
CXM had a positive operating cash flow in 4 of the past 5 years.

1.2 Ratios

CXM's Return On Assets of 5.27% is fine compared to the rest of the industry. CXM outperforms 79.86% of its industry peers.
Looking at the Return On Equity, with a value of 9.70%, CXM belongs to the top of the industry, outperforming 81.27% of the companies in the same industry.
CXM has a better Return On Invested Capital (5.48%) than 79.51% of its industry peers.
Industry RankSector Rank
ROA 5.27%
ROE 9.7%
ROIC 5.48%
ROA(3y)-4.45%
ROA(5y)-6.93%
ROE(3y)-8.06%
ROE(5y)N/A
ROIC(3y)N/A
ROIC(5y)N/A

1.3 Margins

CXM has a Profit Margin of 7.85%. This is in the better half of the industry: CXM outperforms 75.97% of its industry peers.
With a decent Operating Margin value of 5.68%, CXM is doing good in the industry, outperforming 73.50% of the companies in the same industry.
CXM has a Gross Margin of 75.02%. This is in the better half of the industry: CXM outperforms 67.49% of its industry peers.
In the last couple of years the Gross Margin of CXM has grown nicely.
Industry RankSector Rank
OM 5.68%
PM (TTM) 7.85%
GM 75.02%
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y3.33%
GM growth 5YN/A

6

2. Health

2.1 Basic Checks

CXM has a Return on Invested Capital (ROIC), which is below the Cost of Capital (WACC), which means it is destroying value.
Compared to 1 year ago, CXM has more shares outstanding
CXM has no outstanding debt. Therefor its Debt/Equity and Debt/FCF ratios are 0 and belong to the best of the industry.

2.2 Solvency

CXM has an Altman-Z score of 3.52. This indicates that CXM is financially healthy and has little risk of bankruptcy at the moment.
With a Altman-Z score value of 3.52, CXM perfoms like the industry average, outperforming 57.60% of the companies in the same industry.
There is no outstanding debt for CXM. This means it has a Debt/Equity and Debt/FCF ratio of 0 and it is amongst the best of the sector and industry.
Industry RankSector Rank
Debt/Equity 0
Debt/FCF 0
Altman-Z 3.52
ROIC/WACC0.55
WACC10.05%

2.3 Liquidity

CXM has a Current Ratio of 1.92. This is a normal value and indicates that CXM is financially healthy and should not expect problems in meeting its short term obligations.
The Current ratio of CXM (1.92) is comparable to the rest of the industry.
CXM has a Quick Ratio of 1.92. This is a normal value and indicates that CXM is financially healthy and should not expect problems in meeting its short term obligations.
The Quick ratio of CXM (1.92) is comparable to the rest of the industry.
Industry RankSector Rank
Current Ratio 1.92
Quick Ratio 1.92

6

3. Growth

3.1 Past

The Earnings Per Share has grown by an impressive 281.82% over the past year.
The Revenue has grown by 16.76% in the past year. This is quite good.
Measured over the past years, CXM shows a very strong growth in Revenue. The Revenue has been growing by 23.70% on average per year.
EPS 1Y (TTM)281.82%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%50%
Revenue 1Y (TTM)16.76%
Revenue growth 3Y23.7%
Revenue growth 5YN/A
Sales Q2Q%13.03%

3.2 Future

CXM is expected to show quite a strong growth in Earnings Per Share. In the coming years, the EPS will grow by 16.26% yearly.
The Revenue is expected to grow by 8.98% on average over the next years. This is quite good.
EPS Next Y5.24%
EPS Next 2Y10.79%
EPS Next 3Y13.5%
EPS Next 5Y16.26%
Revenue Next Year7.43%
Revenue Next 2Y6.85%
Revenue Next 3Y7.49%
Revenue Next 5Y8.98%

3.3 Evolution

When comparing the Revenue growth rate of the last years to the growth rate of the upcoming years, we see that the growth is decreasing.

4

4. Valuation

4.1 Price/Earnings Ratio

A Price/Earnings ratio of 23.50 indicates a rather expensive valuation of CXM.
Based on the Price/Earnings ratio, CXM is valued a bit cheaper than the industry average as 79.86% of the companies are valued more expensively.
CXM's Price/Earnings ratio indicates a similar valuation than the S&P500 average which is at 24.41.
CXM is valuated rather expensively with a Price/Forward Earnings ratio of 20.62.
Based on the Price/Forward Earnings ratio, CXM is valued a bit cheaper than the industry average as 78.80% of the companies are valued more expensively.
CXM's Price/Forward Earnings ratio indicates a similar valuation than the S&P500 average which is at 20.59.
Industry RankSector Rank
PE 23.5
Fwd PE 20.62

4.2 Price Multiples

Compared to the rest of the industry, the Enterprise Value to EBITDA ratio of CXM indicates a rather cheap valuation: CXM is cheaper than 80.21% of the companies listed in the same industry.
Compared to the rest of the industry, the Price/Free Cash Flow ratio of CXM indicates a somewhat cheap valuation: CXM is cheaper than 70.32% of the companies listed in the same industry.
Industry RankSector Rank
P/FCF 35.82
EV/EBITDA 24.43

4.3 Compensation for Growth

The high PEG Ratio(NY), which compensates the Price/Earnings for growth, indicates an expensive valuation of the company.
CXM's earnings are expected to grow with 13.50% in the coming years. This may justify a more expensive valuation.
PEG (NY)4.48
PEG (5Y)N/A
EPS Next 2Y10.79%
EPS Next 3Y13.5%

0

5. Dividend

5.1 Amount

CXM does not give a dividend.
Industry RankSector Rank
Dividend Yield N/A

SPRINKLR INC-A

NYSE:CXM (7/26/2024, 7:24:17 PM)

After market: 9.38 -0.49 (-4.96%)

9.87

+0.27 (+2.81%)

Chartmill FA Rating
GICS SectorInformation Technology
GICS IndustryGroupSoftware & Services
GICS IndustrySoftware
Earnings (Last)
Earnings (Next)
Inst Owners
Inst Owner Change
Ins Owners
Ins Owner Change
Market Cap2.62B
Analysts
Price Target
Dividend
Industry RankSector Rank
Dividend Yield N/A
Dividend Growth(5Y)
DP
Div Incr Years
Div Non Decr Years
Ex-Date
Surprises & Revisions
EPS beat(2)
Avg EPS beat(2)
Min EPS beat(2)
Max EPS beat(2)
EPS beat(4)
Avg EPS beat(4)
Min EPS beat(4)
Max EPS beat(4)
EPS beat(8)
Avg EPS beat(8)
EPS beat(12)
Avg EPS beat(12)
EPS beat(16)
Avg EPS beat(16)
Revenue beat(2)
Avg Revenue beat(2)
Min Revenue beat(2)
Max Revenue beat(2)
Revenue beat(4)
Avg Revenue beat(4)
Min Revenue beat(4)
Max Revenue beat(4)
Revenue beat(8)
Avg Revenue beat(8)
Revenue beat(12)
Avg Revenue beat(12)
Revenue beat(16)
Avg Revenue beat(16)
PT rev (1m)
PT rev (3m)
EPS NQ rev (1m)
EPS NQ rev (3m)
EPS NY rev (1m)
EPS NY rev (3m)
Revenue NQ rev (1m)
Revenue NQ rev (3m)
Revenue NY rev (1m)
Revenue NY rev (3m)
Valuation
Industry RankSector Rank
PE 23.5
Fwd PE 20.62
P/S
P/FCF
P/OCF
P/B
P/tB
EV/EBITDA
EPS(TTM)
EY
EPS(NY)
Fwd EY
FCF(TTM)
FCFY
OCF(TTM)
OCFY
SpS
BVpS
TBVpS
PEG (NY)4.48
PEG (5Y)N/A
Profitability
Industry RankSector Rank
ROA 5.27%
ROE 9.7%
ROCE
ROIC
ROICexc
ROICexgc
OM 5.68%
PM (TTM) 7.85%
GM 75.02%
FCFM
ROA(3y)
ROA(5y)
ROE(3y)
ROE(5y)
ROIC(3y)
ROIC(5y)
ROICexc(3y)
ROICexc(5y)
ROICexgc(3y)
ROICexgc(5y)
ROCE(3y)
ROCE(5y)
ROICexcg growth 3Y
ROICexcg growth 5Y
ROICexc growth 3Y
ROICexc growth 5Y
OM growth 3Y
OM growth 5Y
PM growth 3Y
PM growth 5Y
GM growth 3Y
GM growth 5Y
F-Score
Asset Turnover0.67
Health
Industry RankSector Rank
Debt/Equity 0
Debt/FCF
Debt/EBITDA
Cap/Depr
Cap/Sales
Interest Coverage
Cash Conversion
Profit Quality
Current Ratio 1.92
Quick Ratio 1.92
Altman-Z
F-Score
WACC
ROIC/WACC
Cap/Depr(3y)
Cap/Depr(5y)
Cap/Sales(3y)
Cap/Sales(5y)
Profit Quality(3y)
Profit Quality(5y)
High Growth Momentum
Growth
EPS 1Y (TTM)281.82%
EPS 3YN/A
EPS 5Y
EPS Q2Q%
EPS Next Y5.24%
EPS Next 2Y
EPS Next 3Y
EPS Next 5Y
Revenue 1Y (TTM)16.76%
Revenue growth 3Y23.7%
Revenue growth 5Y
Sales Q2Q%
Revenue Next Year
Revenue Next 2Y
Revenue Next 3Y
Revenue Next 5Y
EBIT growth 1Y
EBIT growth 3Y
EBIT growth 5Y
EBIT Next Year
EBIT Next 3Y
EBIT Next 5Y
FCF growth 1Y
FCF growth 3Y
FCF growth 5Y
OCF growth 1Y
OCF growth 3Y
OCF growth 5Y